To date, several studies have reported USP22 was predicted as a poor prognostic factor in patients with non-small cell lung cancer, salivary duct carcinoma, papillary thyroid carcinoma and oral squamous cell carcinoma [7], [8], [9], [10]. The gene discussed is USP22; the disease is salivary duct carcinoma.